Previous Article | Next Article ![]()
Infection and Immunity, September 2001, p. 5832-5839, Vol. 69, No. 9
Department of Molecular
Biology1 and Medical Biochemistry,
Department of Medical Biosciences,2 Umeå
University, S-90187 Umeå, Sweden
Received 12 March 2001/Returned for modification 12 April
2001/Accepted 29 May 2001
Borrelia crocidurae is an etiologic agent of
relapsing fever in Africa and is transmitted to humans by the bite of
soft ticks of the genus Ornithodoros. The role of the
plasminogen (Plg) activation system for the pathogenicity of B.
crocidurae was investigated by infection of Plg-deficient
(plg Lyme disease and relapsing fever
(RF) are caused by distinct species of Borrelia (3,
9). Lyme disease, most common in the Northern hemisphere, is
caused by infection by, e.g., Borrelia burgdorferi, B. afzelii, and B. garinii, which are transmitted by the
bite of hard-shelled Ixodes ticks. There are two types of
RF, louse-borne and tick-borne RF. Louse-borne RF is induced by
transmission of B. recurrentis by the crushing of feeding
lice, and tick-borne RF is induced by transmission of, e.g., B. hermsii, B. duttonii, or B. crocidurae by
the bite of soft-shelled Ornithodoros ticks
(9). Lyme disease has been more extensively studied than RF and may involve several organ systems, most prominently the skin,
nervous system, heart, and joints. Disease manifestations are induced
by spirochete invasion of organ tissues, where Borrelia lipoproteins are likely to be involved in the early mechanisms of
immune cell activation (29, 32, 45).
Unlike in Lyme disease, patients with RF experience one or more cycles
of spirochetemia. Each cycle is characterized by a febrile
period with microscopically visible spirochetemia lasting for 3 to 7 days, followed by nonfebrile periods of increasing lengths (18,
19, 40). The relapsing nature of the infection depends on the
ability of the RF spirochetes to undergo antigenic variation, which has
been studied in depth in the North American RF species B. hermsii (4, 7, 41). Similar to Lyme disease Borrelia, RF species also disseminate from the blood to many
distant organs. Symptoms of brain invasion can include meningitis,
focal deficits, hemiplegia, paraplegia, epilepsy, paresthesias, pains, pupillary abnormalities, peripheral and cranial neuritis, and myelitis
(5, 24, 27, 31, 34, 42).
The mechanism by which Borrelia species enter blood and
invade organs is still largely unknown. In higher vertebrates,
plasminogen (Plg), the key component of the fibrinolytic system, can be
converted to plasmin, a broad-spectrum serine protease, by the
tissue-type Plg activator and the urokinase-type Plg activator (uPA)
(6). In addition to fibrinolysis, plasmin-mediated
proteolysis has been associated with many other biological processes,
e.g., macrophage migration, tumor cell invasion, angiogenesis, and
atherosclerosis (6). In vitro, a number of invasive
bacteria have the ability to interact with the Plg activation system by
binding plasmin(ogen) to the bacterial surface and/or by expressing
endogenous Plg activators (12, 26). The activation of
surface-bound Plg to plasmin is suggested to be a mechanism that
enhances their ability to penetrate endothelium and tissue barriers. In
addition, Plg binding may result in direct pathological effects due to
the proteolytic activity of plasmin. Interestingly, besides the
implication of Plg binding in bacterial pathogenicity, a recent study
by Fischer and colleagues suggests that the binding of a pathological
prion protein to Plg is of importance for pathogenicity in
transmissible spongiform encephalopathies (20).
B. crocidurae was first isolated from the blood of a musk
shrew in Senegal and was identified as the cause of endemic RF in western Africa (2, 11, 19, 28, 44), where it is considered a major cause of morbidity and neurologic disease (43).
B. crocidurae organisms have the uncommon (among
Borrelia species) ability to bind and cover themselves with
erythrocytes, a phenomenon called erythrocyte rosetting, which is
thought to result in a delayed immune response in the host
(8). However, B. crocidurae shares with Lyme
disease agents (i.e., B. burgdorferi) the ability to activate the adhesion molecules on the endothelium (35,
36), which could be a key pathophysiologic mechanism in B. crocidurae-induced vascular damage (37, 38). In this
study, we investigated the role of host-derived Plg in the ability of
B. crocidurae to produce spirochetemia and disseminate to organs.
Animals and bacterial strain.
B. crocidurae was
obtained from Alan G. Barbour (Irvine, Calif.), cloned by limiting
dilution to serotype 2, and subsequently used in the infection
experiments (8). BALB/c mice (Bomholtgård, Ry, Denmark)
were used for passage of spirochetes from Dose-dependent coating of B. crocidurae with
plasmin.
Plasmin labeling of spirochetes was done as described
earlier (14). Briefly, B. crocidurae organisms
were cultivated and passaged at least four times in
Barbour-Stoenner-Kelly medium II supplemented with 10% gelatin
but without rabbit sera. Spirochetes were removed from the medium by
centrifugation at 7,000 × g for 20 min. The pellet was
resuspended in Hanks' balanced salt solution (HBSS) and divided into
aliquots. One tube received 0.2 mg of Plg (Biopool, Umeå, Sweden)/ml
and 10 ml (30 IU) of uPA, purchased from Sigma (plasmin labeled). A
second tube received only Plg (Plg labeled), and a third tube received
only uPA (uPA labeled). The fourth tube received HBSS only (untreated).
Another tube (sham) contained Plg and uPA but no spirochetes. All
samples were incubated 90 min at 32°C prior to three washes with HBSS
and addition of FlavigenPli (Biopool), a chromogenic plasmin substrate.
After incubation for 60 min at 32°C, the samples were centrifuged and supernatants were placed in a 96-well plate. The absorbance was read
immediately at 410 nm with an MR700 microplate reader (Dynatech Laboratories, Chantilly, Va.).
Experimental infection.
For revival of frozen B. crocidurae, a passage in mice was performed prior to the animal
experiments. Four BALB/c mice were infected intraperitoneally with
approximately 107 spirochetes. Spirochetemias
were monitored by microscopy of blood sampled daily from the tails.
When the spirochetemia was pronounced, blood was collected in citrate
buffer (0.11 M sodium citrate) by cardiac exsanguination under
anesthesia (Dormicum [Roche, Basel, Switzerland] and Hypnorm
[Janssen, Saunderton, United Kingdom]). Spirochetes were collected by
removing supernatants after centrifugation of citrated blood for 5 s at 8,000 × g and two washes with 500 µl of PBS
(0.02 M phosphate-buffered saline, pH 7.4). Samples were diluted with
PBS, and 15 plg Immunohistochemistry.
Frozen tissues were sectioned to 8 µm using a cryostat (HM505E; Microm, Laborgeräte, GbH,
Walldorf, Germany) and fixed in 50% acetone for 30 s and 100%
acetone at 4°C for 3 min. The sections were kept at
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5832-5839.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Delayed Invasion of the Kidney and Brain by
Borrelia crocidurae in Plasminogen-Deficient
Mice

and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
) and Plg wild-type
(plg+/+) mice. No differences in spirochetemia
were observed between the plg
/
and
plg+/+ mice. However, signs indicative of brain
invasion, such as neurological symptoms and/or histopathological
changes, were more common in plg+/+ mice.
Quantitative immunohistochemical analysis demonstrated infection of
spirochetes in kidney interstitium and brain as soon as 2 days
postinoculation. Lower numbers of extravascular spirochetes in
plg
/
mice during the first days of
infection suggested a less efficient invasion mechanism in these mice
than in the plg+/+ mice. The invasion of the
kidneys in plg
/
mice produced no
significant inflammation, as seen by quantitative immunohistochemistry
of the CD45 common leukocyte marker. However, significant kidney
inflammation was observed with infection in the
plg+/+ mice. In brain, inflammation was more
severe in plg+/+ mice than in
plg
/
mice, and the numbers of
CD45+ cells increased significantly with duration of
infection in the plg+/+ mice. The results show
that invasion of brain and kidney occurs as early as 2 days after
inoculation. Also, Plg is not required for establishment of
spirochetemia by the organism, whereas it is involved in the invasion
of organs.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
80°C to C57BL/6J mice.
Adult Plg-deficient (plg
/
) and Plg
wild-type (plg+/+) mice, generated from
Plg-heterozygous (plg+/
) breeding
pairs, were used for the infection experiments. The plg
/
mice were generated by Carmeliet
et al. (11) and genotyped by a rapid chromogenic assay and
PCR as described by Ny et al. (30).
/
and 15 plg+/+
mice were each inoculated subcutaneously with 0.1 ml containing 105 B. crocidurae organisms. Five
uninfected mice of each category were included as controls. Blood was
sampled from the tail each day for 14 days, diluted 1:10 in citrate
buffer, and spirochetes were quantified in a Petroff-Hausser chamber
using light microscopy. A spirochete was considered positive for
rosette formation when it was attached to at least one erythrocyte. The
mice were examined daily for visible neurological symptoms of
Borrelia infection, as determined by the inability to
coordinate movements when lifted by the tail and/or swimming inability
(10, 38, 39). At day 0 postinoculation (p.i.), the
uninfected mice were anaesthetized as described above and
sacrificed by cardiac exsanguination. At days 2, 5, 8, 12, and 14 p.i., three plg
/
and three
plg+/+ animals were sacrificed similarly.
All mice had been randomly selected for day of sacrifice prior to the
experiment. Organs were immediately perfused in situ with PBS through
the left heart ventricle until the kidneys were macroscopically free of
blood. Tissue samples of heart, brain, and kidneys were fixed with 4% phosphate-buffered formalin, paraffin embedded, sectioned to a 5-µm
thickness, stained with hematoxylin-eosin, and analyzed for histopathological changes. Samples of kidney and brain were embedded in
OCT compound medium (Tissue Tek; Miles Inc. Diagnostics
Division, Elkhart, Ind.) for frozen tissue specimens, snap-frozen in
isopentane prechilled with liquid nitrogen and stored at
80°C until sectioned.
80°C until
use. For staining of immune cells in kidney and brain tissue sections,
endogenous peroxidase activity was blocked by incubation in 3%
H2O2 for 10 min. To block
unspecific binding, the sections were incubated for 30 min with normal
rabbit serum (1:5; GIBCO BRL, Grand Island, N.Y.) followed by avidin and biotin (blocking kit; Vector Laboratories Inc., Burlingame, Calif.)
for 30 min, respectively. Sections were incubated with rat monoclonal
antibody to mouse CD45 (YW62.3; Harlan Sera-Lab Ltd., Loughborough,
England) overnight at 4°C, followed by incubation with biotinylated
rabbit anti-rat antibodies (DAKO Corporation, Carpinteria, Calif.) for
1 h. StreptABComplex-horseradish peroxidase (DAKO) was used
according to the manufacturer's recommendations for amplification of
signals and developed using 3,3-diaminobenzidine tetrahydrochloride
(DAB) chromogen tablets (DAKO). Mayer's hematoxylin (Apoteksbolaget, Malmö, Sweden) was used as a counterstain.
Quantitative analysis of spirochetes and immune cells in kidney tissue. The quantitation of bacteria and immune cells in sequential sections of kidney and brain tissue was performed essentially as described by Hooke et al. (25). Briefly, the number of cells in kidney interstitium and glomeruli, as well as cerebrum and cerebellum, was determined by immunostaining, and values were reported per square millimeter of respective tissue area using an ocular inserted square pattern (01B21210; Graticules Pyser-SGI Ltd., Edenbridge, United Kingdom). Tissue close to the edge of sections was excluded from calculation. A total area of approximately 3.75 mm2 was evaluated per mouse for quantitation of interstitial leukocytes and a glomerular area of about 0.1 mm2 (15 glomeruli) was evaluated for cells located within glomeruli. Approximately 50 mm2 per mouse was evaluated for the presence of spirochetes. The total area evaluated for immune cells included sections taken at two depths of the organs; the area evaluated for spirochetes included three depths. The analyses were performed in a blinded fashion, i.e., the observer did not know the origin of the microscopic sections.
Statistical analysis.
For spirochetemia, the design of the
experiment does not allow a statistical test involving a test statistic
with an asymptotic distribution, because of the small samples at each
time point. Thus, a test of homogeneity between
plg
/
and
plg+/+ mice was made with the Fisher exact
test, with the variable transformed to an indicator variable with value
0 for bacteria in blood and 1 for no bacteria in blood. For analyses of
spirochetes and CD45+ cells in tissues, the
Mann-Whitney test was used. Comparisons of proportions of mice with
clinical and histopathological symptoms (Table
1) were performed according to a normal
approximation of binomial distribution (17). The criterion
for significant differences throughout the material was that the
probability for random occurrence was less than 0.05.
|
| |
RESULTS |
|---|
|
|
|---|
Dose-dependent coating of B. crocidurae with
plasmin.
Addition of Plg to in vitro-cultivated B. crocidurae resulted in dose-dependent coating of the protein to
the surface of the spirochetes. Bound Plg was activated by uPA,
whereupon surface-associated plasmin activity was observed as
proteolysis of a plasmin chromogenic substrate (Fig.
1).
|
Development of spirochetemia and erythrocyte rosetting during
infection.
The plg
/
and
plg+/+ mice exhibited similar patterns and
numbers of spirochetemia (Fig. 2A), and
there were no significant differences between the two groups on any day
(P > 0.05). A test of the order of infection and no
infection was also carried out, showing no significant differences. A
somewhat higher percentage of the spirochetes were found in rosettes
(i.e., were attached to at least one erythrocyte) in
plg
/
mice than in
plg+/+ mice, as seen by mean (Fig. 2B) and
median (data not shown) values. This indication was most prominent
during the first spirochetemic peak, on days 3 to 7 p.i.
Attachment of spirochetes to more than two erythrocytes occurred to the
same degree in the two mouse groups (data not shown).
|
Development of neurological symptoms.
Of the inoculated mice,
three plg+/+ mice and one
plg
/
mouse developed neurological
symptoms. The plg+/+ mice failed both the
coordination and swim tests, whereas the plg
/
mouse failed only the swim test
(Table 1). In all cases, the neurological symptoms appeared on day
8 p.i. The symptoms persisted until the day of sacrifice, i.e.,
day 12 p.i. for two of the plg+/+
mice. The other two symptomatic mice were sacrificed on the day of the
appearance of symptoms, day 8 p.i., due to the method of random
selection for day of sacrifice which was used. The spirochetemias did
not differ between mice with or without neurological symptoms, as seen
by comparison of both mean and median values.
Quantitative analysis of spirochetes and inflammation.
Representative staining of spirochetes in kidney, brain, and
CD45+ cells, histopathology, and endothelial
staining are illustrated in Fig. 3. The
localization of spirochetes in the organs was similar to earlier
findings (38). The overall pattern of detected
extravascular spirochetes in kidney tissue paralleled the pattern of
spirochete fluctuation observed in blood, with the highest number of
spirochetes detected at day 5 p.i. also in the tissue, and with
the next peak at day 14 p.i. (Fig.
4A). The corresponding pattern was
indicated to also occur in brain (Fig. 4B). The spirochetes were most
often demonstrated in the proximity of blood vessels on days 2 and
5 p.i., whereas they were detected further away and more
homogeneously across the sections at later stages. Among
plg
/
mice, the number of spirochetes
detected in interstitium increased with time and at day 8 p.i.
approached those observed on day 2 p.i. in
plg+/+ mice. The difference in spirochete
numbers in kidney interstitium was significant early, i.e., days 2 to
5 p.i. (P = 0.02), and stayed significant
throughout the first spirochetemic peak, i.e., days 2 to 8 p.i.
(P = 0.04).
|
|
/
mice. Similar numbers of
spirochetes were demonstrated in the mouse groups on day 5 p.i.,
with a tendency toward higher numbers on days 8 and 12 in
plg+/+ mice. Spirochetes in the process of
extravasating were frequently detected (data not shown). Double
staining of spirochetes and PECAM-1, an endothelial marker, was
performed to confirm the extravascular location of spirochetes. The
numbers of spirochetes associated with endothelium were the same for
plg+/+ and plg
/
mice.
On day 2 p.i., an average of 71% of all spirochetes detected in
brains of plg+/+ mice were located
extravascularly, compared to 25% in plg
/
mice.
The numbers of CD45+ cells were higher in both
kidney interstitium and glomeruli of plg+/+ mice
than of plg
/
mice (Fig.
5). There was a significant inflammatory
response in glomeruli of plg+/+ mice during the
entire process (P = 0.02, days 2 to 14 p.i.), most
pronounced on days 2 to 5 (P = 0.01), but not in
plg
/
mice (P > 0.05).
The difference in inflammation was significant early, i.e., days 2 to
5 p.i. (P = 0.02). Similarly, in interstitium, more CD45+ cells were present in
plg+/+ mice than in
plg
/
mice (P = 0.03, days 2 to 14 p.i.). The difference was established early, i.e., days 2 to
5 p.i. (P = 0.03). No significant inflammation was
detected in interstitium of plg
/
mice
(P > 0.05), although a slight increase was
indicated on days 8 to 12 p.i.
|
/
mice (P = 0.047)
(Fig. 6). From day 2 p.i., numbers
of leukocytes increased, and throughout the infection process, a
decline was indicated only in plg
/
mice on day 14 p.i. In contrast, regression analysis showed an increase in CD45+ cells over time, from day 2 to
14 p.i., in the brains of plg+/+ mice
(P = 0.001).
|
Histopathology.
Histopathological changes were detected in two
plg
/
mice and eight
plg+/+ mice (Fig. 3F). Changes in
plg
/
mice were observed in kidney and
central nervous system samples. Changes in
plg+/+ mice also included heart and were more
common in all three organs (Table 1). Clinical signs of central nervous
system involvement were detected in one additional
plg
/
mouse (one total) and one additional
plg+/+ mouse (three total). Thus, signs of brain
invasion, as indicated by histopathological and/or clinical symptoms,
were more commonly found among plg+/+ mice (7 of
15) than plg
/
mice (2 of 15)
(P < 0,05). Whereas the symptoms in
plg+/+ mice were detected on all days of
sacrifice from day 8 p.i. onward, except for a heart symptom on
day 2 p.i., any symptoms in plg
/
mice
were seen on day 8 p.i. and were absent on the later days of
sacrifice. A larger proportion of mice with histopathological and/or
clinical symptoms of organ invasion was found in the
plg+/+ mouse group than in the
plg
/
group (P = 0.03).
/
mouse with histopathological changes in
the brain showed focal cell infiltrates of mononuclear leukocytes in a
single site in meninges.
Histopathological symptoms observed in kidneys in
plg+/+ mice included capillary thrombi in
medullary rays as well as a perivascular infiltrate showing mononuclear
leukocytes, with several protein casts in tubuli of the inner cortex.
In the plg
/
mouse, the symptoms were
leukocyte infiltration of perirenal fat tissues.
Symptoms in hearts were acute focal myocardial degeneration and
interstitial myocarditis on day 8 p.i. and chronic myocardial degeneration on days 2 and 14 p.i.
| |
DISCUSSION |
|---|
|
|
|---|
Binding of Plg to the surface of bacteria has been proposed to be of importance for the invasion capacity of a number of pathogenic bacterial species belonging to several genera, including Borrelia (13, 16, 22). So far, in vivo studies of the role of Plg binding in pathogenicity have been performed for few organisms. Two such studies have been performed for Borrelia species, i.e., the Lyme disease species B. burgdorferi and a hitherto-uncharacterized Spanish RF isolate, and have indicated a role for Plg binding at different stages of the pathogenic process for the two species (15, 23). Whereas Plg binding appeared to be important for tissue invasion but not for the capacity to cause spirochetemia for the RF species, the opposite was indicated for the Lyme disease species. A major hindrance to evaluating invasion has been the requirement to use PCR for detection, due to the low numbers of spirochetes in tissues. Thus, until now, studies of in vivo invasion have required analysis at later stages of the infection process, when the blood is free from spirochetes with contaminating DNA. Thus, it is not clear if differences observed in spirochete load at later stages were due to utilization of Plg in invasion or in spreading through tissue postinvasion. As B. crocidurae invades organs in unusually (for Borrelia) high numbers, quantitative immunohistochemistry could be used to evaluate invasion during the early phase of infection. In addition to brain, which is known to be inflamed after infection of mice with the Spanish RF isolate (1, 21) and B. crocidurae (38), kidney was analyzed for invasion and inflammation, as the organ is consistently inflamed during murine B. crocidurae infection (38).
In this study, we show that Plg is not required for B. crocidurae to cause spirochetemia, as no differences could be
observed in spirochetemic patterns between
plg+/+ and plg
/
mice.
The findings that both the rosette-forming B. crocidurae and
a nonrosetting Spanish RF isolate (1, 23) use a
Plg-independent mechanism to establish spirochetemia is intriguing, as
it indicates that RF species may use a different mechanism(s) than Lyme
disease Borrelia to accomplish this step. Tick-borne RF
spirochetes are transmitted quickly by species of
Ornithodoros that feed for 2 h or less. In contrast,
Lyme disease spirochetes generally are not transmitted until after
48 h or more by the slow-feeding species of Ixodes
ticks (33). Whether these differences may be attributed to
different mechanisms used by the bacteria to spread and/or cross the
endothelium from the site of infection or are related to different
feeding mechanisms of the tick species remains to be elucidated.
Erythrocyte rosettes have been proposed to be a mechanism for B. crocidurae spirochetes to evade the immune response to the organism (8, 38). Thus, the rosetting may provide a longer period during which the bacteria can reach and invade distant organs as
well as be ingested by new ticks. A slightly but not significantly
higher rate of rosette formation was observed in plg
/
mice than plg+/+
mice. A possible explanation for this finding may be that plasmin plays
a role in the resolution of spirochete-erythrocyte complexes. However,
if this is true, the importance of plasmin(ogen) for such a resolution
appears to be limited, as no difference was observed between the mouse
groups in formation of larger rosettes, i.e., when the criterion was
binding to at least two erythrocytes per bacterium.
Despite similar spirochetemias, there was a higher incidence of
symptoms of organ invasion in plg+/+ mice than
in plg
/
mice.
Spirochetes were also demonstrated in greater numbers in kidney
interstitium of plg+/+ than
plg
/
mice, where the slowly increasing
numbers in plg
/
kidneys on day 8 p.i.
were similar to those reached on day 2 p.i. in
plg+/+ mice. The interstitial spirochetes were
most often demonstrated close to blood vessels during the early phase,
days 2 and 5 p.i., of the infection period, whereas they were
further away from vessels at later stages, day 8 p.i. and onward.
Thus, the spirochetes have the ability to move rather rapidly through
the interstitium. A corresponding delayed invasion was also indicated
in brains of plg
/
mice. By the method used,
spirochetes were detected on day 2 p.i. in brain, which is the
earliest demonstration of B. crocidurae in this tissue. The
findings of extravascular spirochetes on day 2 p.i. in both kidney
and brain, despite the high integrity of the blood-brain barrier,
points to a very high efficiency of barrier crossing by B. crocidurae.
All spirochetes detected on day 2 p.i. were unassociated with
cells, which indicates that the mechanism of crossing the blood-brain barrier is not accomplished by "hitchhiking" with other cell
types. The delayed invasion into both organs of
plg
/
mice strongly indicates that Plg aids
the bacterium to accomplish this step.
The frequency of spirochete dissemination from the blood to brain was
high: 93.3% in plg+/+ and 53.3% in
plg
/
mice with brain invasion and 86.7% in
plg+/+ and 60% in
plg
/
mice with kidney invasion. For brain,
the numbers of mice with spirochetes associated with vessels on day
2 p.i. were the same, i.e., two in each group, and no
apparent difference between the mouse groups was noted in the numbers
of spirochetes associated with vessels at this stage. Despite this
fact, a higher percentage of all spirochetes detected in brain were
located extravascularly in plg+/+ mice than in
plg
/
mice on day 2 p.i. This finding
may indicate that the association with, and possibly adhesion to,
vessels is the same whether Plg is present or not and that the
Plg-related difference is to be found in the actual barrier crossing.
Spirochetes were competent at invading both kidney and brain of
plg
/
mice, although seemingly by a less
efficient mechanism than in plg+/+ mice. As
opposed to the difference observed on day 2 p.i., no differences
were seen in numbers of Borrelia organisms in brains of
plg+/+ and plg
/
mice
on day 5 p.i. In addition, the presence of RF Borrelia
in tissues of plg
/
mice on day 28 to 30 p.i. has been reported by Gebbia and colleagues (23).
Thus, at least one additional mechanism of invasion other than Plg
binding is used by these RF species. Rosette formation may contribute
to organ invasion, by a resulting burst of blood vessels, a mechanism
that may explain the high invasion efficiency of this organism compared
to nonrosetting species. However, as DNA of the Spanish RF isolate was
demonstrated in heart and brain tissue of
plg
/
mice although it does not form
erythrocyte rosettes, rosetting is not the sole explanation for
Plg-independent invasion among RF Borrelia
(23). Whether the Plg-dependent and Plg-independent invasion mechanisms are mutually exclusive or acting in synergy remains
to be elucidated. Borrelia spirochetes have been shown to
activate matrix metalloproteinases, and a differential activation pattern was indicated when plasmin was bound to the bacterial surface
(22). Thus, the different capabilities of invading organs observed in the present study may in part be related to differential activation of matrix metalloproteinases in the presence or absence of Plg.
A general assessment of inflammation was accomplished by quantification
of the number of CD45+ cells in situ in brain as
well as kidney glomeruli and interstitium. Both kidney compartments
were significantly inflamed in plg+/+ but not in
plg
/
mice, although a slight, but not
significant, increase in inflammatory cells was indicated over time in
interstitium of the latter mice. During the first 5 days of infection,
a slight increase in CD45+ cells was seen
in brains of plg+/+ and
plg
/
mice. On day 8 p.i. and at later
stages, the inflammation tended to be more pronounced in
plg+/+ than in plg
/
mice, which fits with the more commonly demonstrated occurrence of mice
with histopathological and/or clinical symptoms and the indication of a
higher total spirochete burden in brains of
plg+/+ mice. The inflammation was shown to be
more severe in the brains of plg+/+ mice on day
2 to 14 p.i. than in plg
/
mice.
Thus, the Plg-independent mechanism for invading tissues was not sufficient to gain numbers high enough to cause significant inflammation or other investigated symptoms of organ invasion.
Despite the lower degree of invasion which resulted in the
plg
/
mice showing less severe symptoms,
spirochetes that have invaded with low efficiency may have the capacity
to persist in the tissues for an extended length of time, as indicated
by the presence of spirochetes in brains and kidneys of
plg
/
mice on day 14 p.i. in the present
study and by the study by Gebbia and colleagues (23),
where spirochetes were present in low numbers in
plg
/
mice on days 28 to 30 p.i. after
infection with a Spanish RF isolate. Thus, the findings indicate that
spirochete invasion in low numbers may lead to absence of invasion
sequelae, masking a process during which the asymptomatic individual
may acquire Borrelia persistently residing in tissues. The
extent to which spirochetes residing in low numbers are associated with
low-grade inflammation that does not manifest as clinical symptoms and
the extent to which such spirochetes may cause a more significant inflammation at a later stage are unclear at this point.
Whereas inflammation in plg+/+ mice showed a tendency to decrease in glomeruli after the first spirochetemic peak, and possibly in interstitium day 14 p.i., no obvious indication of a decrease was observed in brain, despite decreased detection of spirochetes. In contrast, an increase of CD45+ cells over time was observed in the brains of these mice. Further investigations of the longer perspective of inflammatory changes in the brain, as a result of B. crocidurae infection, should be of great interest for evaluating the long-term effects of spirochete invasion.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by the Swedish Medical Research Council (07922), the Swedish Foundation for Strategic Research (Infection and Vaccinology), and the Medical and Odontological Faculty of Umeå university.
For statistical consultation, we thank Ingeborg Nordström and Per
Arnqvist for evaluating spirochetemia and tissue data, respectively. We
are grateful to Tor Ny for providing us with plg
/
and plg+/+ mice
and to Tom Schwan for critical reading and discussion of the manuscript.
The first two authors contributed equally to this work.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Biology, Umeå University, S-90187 Umeå, Sweden. Phone: 46 90 7856735. Fax: 46 90 772630. E-mail: annika.nordstrand{at}micro.umu.se.
Present address: Karolinska Institute, Microbiology and Tumor Biology
Center, S-17177 Stockholm, Sweden.
Present address: Department of Public Health and Clinical Medicine,
Section for Dermatology and Venereology, Umeå University, S-901 87 Umeå, Sweden.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anda, P., W. Sánchez-Yebra, M. del Mar Vitutia, E. Perez Pastrana, I. Rodríguez, N. S. Miller, P. B. Backenson, and J. L. Benach. 1996. A new Borrelia species isolated from patients with relapsing fever in Spain. Lancet 348:162-165[CrossRef][Medline]. |
| 2. | Aubry, P., J. Renambot, J. Teyssier, Y. Buisson, G. Granic, G. Brunetti, P. Dano, and P. Bauer. 1983. Borreliosis caused by ticks in Senegal; apropos of 23 cases. Dakar Med. 28:413-420[Medline]. |
| 3. |
Barbour, A. G., and S. F. Hayes.
1986.
Biology of Borrelia species.
Microbiol. Rev.
50:381-400 |
| 4. |
Barstad, P. A.,
J. E. Coligan,
M. G. Raum, and A. G. Barbour.
1985.
Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides.
J. Exp. Med.
161:1302-1314 |
| 5. |
Bergeret, C., and A. Raoults.
1948.
Notes sur les formes nerveuses de la fievre recurrente fievre recurrente a tiques en Afrique Occidentale Francaise.
Bull. Med. Afr. Occidentale Fr.
5:271-279.
|
| 6. |
Bugge, T. H.,
M. J. Flick,
C. C. Daugherty, and J. L. Degen.
1995.
Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.
Genes Dev.
9:794-807 |
| 7. | Burman, N., S. Bergström, B. I. Restrepo, and A. G. Barbour. 1990. The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosomes. Mol. Microbiol. 4:1715-1726[CrossRef][Medline]. |
| 8. |
Burman, N.,
A. Shamaei-Tousi, and S. Bergström.
1998.
The spirochete Borrelia crocidurae causes erythrocyte rosetting during relapsing fever.
Infect. Immun.
66:815-819 |
| 9. | Cadavid, D., and A. G. Barbour. 1998. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin. Infect. Dis. 26:151-164[Medline]. |
| 10. |
Cadavid, D.,
D. D. Thomas,
R. Crawley, and A. G. Barbour.
1994.
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis.
J. Exp. Med.
179:631-642 |
| 11. | Carmeliet, P., L. Achoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424[CrossRef][Medline]. |
| 12. | Colebunders, R., P. De Serrano, A. Van Gompel, H. Wynants, K. Blot, E. Van den Enden, and J. Van den Enden. 1993. Imported relapsing fever in European tourists. Scand. J. Infect. Dis. 25:533-536[Medline]. |
| 13. | Coleman, J. L., and J. L. Benach. 1999. Use of the plasminogen activation system by microorganisms. J. Lab. Clin. Med. 134:567-576[CrossRef][Medline]. |
| 14. | Coleman, J. L., and J. L. Benach. 2000. The generation of enzymatically active plasmin on the surface of spirochetes. Methods 21:133-141[CrossRef][Medline]. |
| 15. | Coleman, J. L., J. A. Gebbia, J. Piesman, J. L. Degen, T. H. Bugge, and J. L. Benach. 1997. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89:1111-1119[CrossRef][Medline]. |
| 16. | Coleman, J. L., T. J. Sellati, J. E. Testa, R. R. Kew, M. B. Furie, and J. L. Benach. 1995. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect. Immun. 63:2478-2484[Abstract]. |
| 17. | Colton, T. 1974. Inference on proportions, p 151-188. In T. Colton (ed.) In Statistics in medicine. Little, Brown and Co., Boston, Mass. |
| 18. | Felsenfeld, O. 1965. Borrelia, human relapsing fever, and the parasite-vector-host relationships. Bacteriol. Rev. 342:1213-1215. |
| 19. | Felsenfeld, O. 1968. Borrelia: strains, vectors, human and animal borreliosis. Warren H. Green Inc., St. Louis, Mo. |
| 20. | Fischer, M. B., C. Roecki, P. Paricek, H. P. Schwartz, and A. Aguzzi. 2000. Binding of disease-associated prion protein to plasminogen. Nature 408:479-483[CrossRef][Medline]. |
| 21. | Garcia-Monco, J. C., N. S. Miller, P. B. Backenson, P. Anda, and J. L. Benach. 1997. A mouse model of Borrelia meningitis after intradermal injection. J. Infect. Dis. 175:1243-1245[Medline]. |
| 22. |
Gebbia, J. A.,
J. L. Coleman, and J. L. Benach.
2001.
Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells.
Infect. Immun.
69:456-462 |
| 23. | Gebbia, J. A., J. C. Monco, J. L. Degen, T. H. Bugge, and J. L. Benach. 1999. The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J. Clin. Investig. 103:81-87[Medline]. |
| 24. | Goubau, P. F. 1984. Relapsing fevers. A review. Ann. Soc. Belge Med. Trop. 64:335-364[Medline]. |
| 25. | Hooke, D. H., D. C. Gee, and R. C. Atkins. 1987. Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int. 31:964-972[Medline]. |
| 26. | Klempner, M. S., R. Noring, M. P. Epstein, B. McCloud, and R. A. Rogers. 1996. Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species. J. Infect. Dis. 174:97-104[Medline]. |
| 27. | Levaditi, C., and T. Anderson. 1928. Neurotropisme du Spirochaeta duttoni. C. R. Acad. Sci. 186:653-654. |
| 28. | Mooser, H. 1958. Die Rückfallfeber. Ergeb. Mikrobiol. 31:184-229. |
| 29. | Nordstrand, A., A. G. Barbour, and S. Bergström. 2000. Borrelia pathogenesis research in the post-genomic and post-vaccine era. Curr. Opin. Microbiol. 3:86-92[CrossRef][Medline]. |
| 30. |
Ny, A.,
G. Leonardsson,
A.-C. Hägglund,
P. Hägglöf,
V. A. Ploplis,
P. Carmeliet, and T. Ny.
1999.
Ovulation in plasminogen-deficient mice.
Endocrinology
140:5030-5035 |
| 31. | Olchovsky, D., A. Pines, M. Sadeh, N. Kaplinsky, and O. Frankl. 1982. Multifocal neuropathy and vocal cord paralysis in relapsing fever. Eur. Neurol. 21:340-342[Medline]. |
| 32. | Radolf, J. D., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866-2877[Abstract]. |
| 33. | Schwan, T. 1996. Ticks and Borrelia: model systems for investigating pathogen-arthropod interactions. Infect. Agents Dis. 5:167-181[Medline]. |
| 34. | Scott, R. 1944. Neurological complications of relapsing fever. Lancet 247:436-438[CrossRef]. |
| 35. | Sellati, T. J., M. J. Burns, M. A. Ficazzola, and M. B. Furie. 1995. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect. Immun. 63:4439-4447[Abstract]. |
| 36. | Shamaei-Tousi, A., M. J. Burns, J. L. Benach, M. B. Furie, E. I. Gergel, and S. Bergström. 2000. The relapsing fever spirochete, Borrelia crocidurae, activates human endothelial cells and promotes the transendothelial migration of neutrophils. Cell. Microbiol. 2:591-599[CrossRef][Medline]. |
| 37. |
Shamaei-Tousi, A.,
O. Collin,
A. Bergh, and S. Bergström.
2001.
Testicular damage by microcirculatory disruption and colonization of an immune privileged site during Borrelia crocidurae infection.
J. Exp. Med.
193:1-11 |
| 38. | Shamaei-Tousi, A., P. Martin, A. Bergh, N. Burman, T. Brännström, and S. Bergström. 1999. Erythrocyte-aggregating relapsing fever spirochete Borrelia crocidurae induces formation of microemboli. J. Infect. Dis. 180:1929-1938[CrossRef][Medline]. |
| 39. | Simpson, S. 1988. Ataxia, head tilt, nystagmus, circling, and hemiparesis, p 257. In R. B. Ford (ed.), Clinical signs and diagnosis in small animal practice. Churchill Livingstone, New York, N.Y. |
| 40. | Southern, P., and J. Sanford. 1969. Relapsing fever: a clinical and microbiological review. Medicine 48:129-149. |
| 41. |
Stoenner, H. G.,
T. Dodd, and C. Larsen.
1982.
Antigenic variation of Borrelia hermsii.
J. Exp. Med.
156:1297-1311 |
| 42. | Taft, W., and J. Pike. 1945. Relapsing fever. Report of a sporadic outbreak including treatment with penicillin. JAMA 129:1002-1005. |
| 43. | Trape, J. F., J. M. Duplantier, H. Bouganali, B. Godeluck, F. Legros, J. P. Cornet, and J. L. Camicas. 1991. Tick-borne borreliosis in West Africa. Lancet 337:473-475[CrossRef][Medline]. |
| 44. | Trape, J. F., B. Godeluck, G. Diatta, C. Rogier, F. Legros, J. Albergel, Y. Pepin, and J. M. Duplantier. 1996. The spread of tick-borne borreliosis in West Africa and its relationship to sub-Saharan drought. Am. J. Trop. Med. Hyg. 54:289-293. |
| 45. | Vidal, V., I. G. Scragg, S. J. Cutler, K. A. Rockett, D. Fekade, D. A. Warrell, D. J. Wright, and D. Kwiatkowski. 1998. Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever. Nat. Med. 4:1416-1420[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|